Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
HSK-42360 in Glioblastoma Harboring BRAF V600 Mutation: NCT07158710 Clinical Landscape Report 2026
18 September 2026
NCT07158710 clinical landscape for Glioblastoma Harboring BRAF V600 Mutation: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
Oncolytic virus(Mianyang Central Hospital) in Recurrent Glioblastoma: NCT07145047 Clinical Landscape Report 2026
18 September 2026
NCT07145047 clinical landscape for Recurrent Glioblastoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SG-001 (SineuGene) in Amyotrophic Lateral Sclerosis: NCT07169175 Clinical Landscape Report 2026
18 September 2026
NCT07169175 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Treprostinil palmitil in Alveolitis, Extrinsic Allergic: NCT07179380 Clinical Landscape Report 2026
18 September 2026
NCT07179380 clinical landscape for Alveolitis, Extrinsic Allergic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Riluzole in Amyotrophic Lateral Sclerosis: NCT07174492 Clinical Landscape Report 2026
18 September 2026
NCT07174492 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
COYA-302 in Amyotrophic Lateral Sclerosis: NCT07161999 Clinical Landscape Report 2026
18 September 2026
NCT07161999 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Perflutren lipid microsphere in Glioblastoma Multiforme: NCT07179328 Clinical Landscape Report 2026
18 September 2026
NCT07179328 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Atorvastatin Calcium in Metabolic Dysfunction Associated Steatohepatitis: NCT07180745 Clinical Landscape Report 2026
18 September 2026
NCT07180745 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Rifaximin in Metabolic Dysfunction Associated Steatohepatitis: NCT07185932 Clinical Landscape Report 2026
18 September 2026
NCT07185932 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
9 min read
Betabart in Ovarian Cancer: NCT07189871 Clinical Landscape Report 2026
18 September 2026
NCT07189871 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MT-125 in Glioblastoma Multiforme: NCT07185880 Clinical Landscape Report 2026
18 September 2026
NCT07185880 clinical landscape for Glioblastoma Multiforme: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TNBC(ProteinQure) in Locally Advanced Malignant Solid Neoplasm: NCT07190469 Clinical Landscape Report 2026
18 September 2026
NCT07190469 clinical landscape for Locally Advanced Malignant Solid Neoplasm: endpoints, sponsor, phase, geography, readouts, asset context and development w…